FeelGood vs Noom Med: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Noom Med beats FeelGood overall, scoring 7.4/10 vs 7/10. Noom Med is more affordable at $99/mo vs $149/mo. Choose FeelGood for budget-conscious cash-pay patients who want low-cost compoun. Choose Noom Med for users who want a tiered entry into glp-1 care, from $99/mo m.
A side-by-side look at FeelGood and Noom Med to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
FeelGood
#47 of 53Telehealth platform offering compounded semaglutide as both a weekly injection ($149/mo starting) and a daily oral tablet ($249/mo starting), plus a premium brand-name 'original' semaglutide injection option ($1,999/mo). Cash-pay only, no insurance billing, HSA/FSA eligible. LegitScript-approved. FeelGood does not publicly disclose which states it serves, its compounding pharmacy, or its medical leadership.
Visit FeelGoodNoom Med
#27 of 53Noom restructured Noom Med in 2026 into 3 tiers: $69/mo branded telehealth (med out-of-pocket), $99-149/mo Microdose GLP-1Rx (low-dose + biomarker monitoring), and the Full GLP-1Rx program ($149 intro → $349/mo on 12-week subscription). Coaching app included at every tier.
Visit Noom Med| Feature | FeelGood | Noom Med |
|---|---|---|
| Our Score | 7/10 | 7.4/10 |
| Starting Price | $149/mo | $99/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | Yes |
| Best For | Budget-conscious cash-pay patients who want low-cost compounded semaglutide, injection or oral tablet, with free shipping, no membership fees, and a money-back weight-loss guarantee | Users who want a tiered entry into GLP-1 care, from $99/mo Microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program |
| Ranking | #47 | #27 |
| Get started | Visit FeelGood | Visit Noom Med |
Pros & Cons Compared
FeelGood
Pros
- +Compounded semaglutide injection from $149/mo with free shipping and no separate membership or consultation fee
- +Offers an oral compounded semaglutide tablet ($249/mo) for needle-averse patients, a non-injectable route only a handful of platforms provide
- +LegitScript-approved, independent certification that the telehealth/pharmacy operation meets legal and safety standards, which many budget compounded shops lack
- +Money-back weight-loss guarantee plus unlimited 24/7 messaging and appointments included
Cons
- −Does NOT publicly disclose which US states it serves, you can't confirm availability in your state before starting an intake
- −$149 is a 'starting' price (dose-escalating), not flat across all doses, your cost can rise as your dose titrates up, and FeelGood doesn't publish the full dose-by-dose schedule
- −Brand-name 'original' semaglutide injection at $1,999/mo is far above market, NovoCare direct Wegovy is $349/mo and Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership. Never buy brand-name through FeelGood
- −No named medical director, prescribing physicians, compounding pharmacy, founding year, or headquarters disclosed on the site, thin corporate and clinical transparency
- −Self-reported '4.8/5' rating is not tied to a named third-party platform (no linked Trustpilot/BBB), so it can't be independently verified; the advertised '15–20% weight loss' figures are FeelGood's marketing, not FDA-reviewed efficacy data
- −Compounded GLP-1s are not FDA-approved (none are), and FeelGood offers compounded semaglutide only, no tirzepatide
Noom Med
Pros
- +Tiered 2026 entry, $69/mo branded telehealth tier lets users start with just medication access and the coaching app
- +New Microdose GLP-1Rx program ($99-149/mo), low-dose GLP-1 + biomarker monitoring for sensitive users
- +Insurance accepted for qualifying plans, can significantly reduce out-of-pocket costs on brand-name meds
- +Industry-leading behavioral coaching app with years of psychology-based weight loss methodology
Cons
- −Tiered pricing creates confusion, $69, $99-149, or $149-349 depending on tier
- −Full GLP-1Rx program requires 12-week subscription ($149 intro rate applies only for the first few weeks)
- −Medication costs on the $69 tier are out-of-pocket, the low tier price is just the platform
- −App coaching still requires real engagement, skip-prone users waste the behavioral value
Our Verdict
Noom Med edges out FeelGood with a score of 7.4/10 vs 7/10. If budget is your priority, Noom Med starts at $99/mo compared to FeelGood's $149/mo. Noom Med accepts insurance, which can significantly reduce your out-of-pocket costs. Choose FeelGood if you want: budget-conscious cash-pay patients who want low-cost compounded semaglutide, injection or oral tablet, with free shipping, no membership fees, and a money-back weight-loss guarantee. Choose Noom Med if you want: users who want a tiered entry into glp-1 care, from $99/mo microdose all-in (low-dose + biomarkers + coaching) up to a full $349/mo medication + coaching program.
Still undecided? Editor's Featured Pick
TrimRx
$149/mo · 7.8/10 · Compounded
If neither FeelGood nor Noom Med feels like the right fit, our featured pick across all 53 GLP-1 telehealth providers is TrimRx. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $149/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing FeelGood or Noom Med tend to look at next.
- FeelGood vs MEDVi$179/mo
- FeelGood vs bmiMD$119/mo
- FeelGood vs Found$129/mo
- Noom Med vs WeightWatchers (Sequence)$74/mo
- Noom Med vs Sprout Health$199/mo
- Noom Med vs Enhance MD$212/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.